Company Announcements Life Technologies named Rhenium its principal distributor in Israel. MP Biomedicals appointed Todd R. Nelson, PhD, as president and CEO in December 2011. He was formerly CEO of eBioscience. Avacta acquired Aptuscan, a developer of affinity protein scaffolds, in January for £1.5 million ($2.3 million). Under a license and supply agreement, Hologic will […]
Company Announcements ArcticZymes signed a new supply agreement with Affymetrix for its Shrimp Alkaline Phosphatase enzyme covering September 2011 through December 2017. Affymetrix previously held exclusive distribution rights. GE Healthcare Life Sciences exclusively licensed the patent and know-how from Affitech in October 2011 for products containing recombinant Protein L. EMD Millipore will be the initial […]
Due to the IBO January 15, 2012, forecast issue, a condensed version of the third-quarter IBO Lab Equipment/Consumables Index is presented in this issue. Third-quarter revenues for the Index grew 6.4%, 4.2% organically, to $3,834.8 million. Operating profits rose 4.9% to $707.2 million. Adjusted operating margin improved 50 basis points to 17.7% of sales. Kewaunee […]
Company Announcements Horizon Discovery exclusively licensed in August new X-MAN (gene X-Mutant And Normal) cell lines from the University of Minnesota. Baseclick announced in August that it raised an additional €1.2 million ($1.7 million) from private investors and BASF Venture Capital in a second financing round. In September, ABR-Affinity BioReagents, a Thermo Fisher Scientific company, […]
Company Announcements First-half sales for Lonza’s Bioscience declined 2.8% to CHF 103 million ($114 million), but grew 13.2% in local currency, to make up 9% of company revenues. Within the unit, Research Solutions sales declined, with European sales up, US sales down slightly and growth in Asia Pacific. Under a reagent supply agreement announced in […]
Company Announcements In May, New England Biolabs opened a subsidiary in France, just south of Paris. Life Technologies exclusively licensed in June Transcription Activator-Like (TAL) Effector Technology for “plant research tool uses.” The technology enables synthetic biologists to program and control the genetic circuitry in engineered pathways and organisms. In a June SEC filing, Stemgent […]
Company Announcements Cellular Dynamics raised $30 million in April in a Series B Preferred Stock financing, led by an entity affiliated with Tactics II Stem Cell Ventures. New England Biolabs named two new exclusive distributors, extending it distribution network to 39 firms: BIOKE for Belgium, the Netherlands, and Luxembourg; and Imperial Life Sciences for India. […]
Company Announcements Under a license from the US Army Medical Research Institute of Infectious Diseases, Akonni Biosystems plans to commercialize low-cost, multiplexed tests for research and IVD uses in bio-security applications. The tests are expected to be available in 2012. In February, GE Capital, Healthcare Financial Services was the agent for and lender of $55 […]
Company Announcements Netherlands-based Hycult Biotechnology, a developer of antibodies and antibody-based products for innate immunity and directly related fields, opened a US subsidiary in Plymouth Meeting, Pennsylvania, in December 2010. Akonni Biosystems initiated an $8 million equity offering in December 2010, according to an SEC filing. Kreatech Diagnostic announced in January an additional license and […]
Radnor, PA 2/1/11—VWR International has acquired AMRESCO, a manufacturer and supplier of biochemicals and reagents for molecular biology, life sciences, proteomics, clinical and histology areas of research and production. Financial details were not disclosed. “This acquisition expands VWR’s product portfolio in the growing and critical life science arena,” stated VWR Chairman, President and CEO John […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
